Recent studies have shown that the synergistic regulation of the AS factor SF3B3 and RNA binding protein RALY leads to a decrease in MTA1-S levels, enhances the expression of cholesterol synthesis genes, and promotes HCC cell proliferation [10]. This evidence concerns the gene RALY and hepatocellular carcinoma.